Gastroenterology

A UK Biobank study finds aspirin users with multiple cardiometabolic risk factors—such as diabetes and hypertension—have nearly double the risk of GI bleeding.

A randomised trial shows 200 mg simethicone with PEG-ELS is as effective as 1200 mg for bowel cleansing and adenoma detection in afternoon colonoscopy.

A nationwide Icelandic study confirms an ICD-10 algorithm accurately identifies major GI bleeding in anticoagulated patients, improving reliability of registry-based research.

New ESSENCE trial data show semaglutide improves liver histology and non-invasive markers in MASH through mechanisms beyond weight loss, highlighting dual metabolic benefits.

New joint statement from United European Gastroenterology and the German Society for Gastroenterology calls for coordinated prevention, early detection, and policy reform to reverse the rising tide of liver cancer across Europe.

Discover a new study showing both sugary and artificially sweetened drinks raise the risk of liver disease, with water emerging as the healthiest choice.

Discover a study showing how microplastics alter the gut microbiome, with changes linked to digestion, depression, and colorectal cancer risk.

A real-world study finds upadacitinib induces remission and mucosal healing in biologic-refractory Crohn’s disease patients, confirming its effectiveness and safety.